NVIDIA Shares Edge Up 0.8% as Earnings Beat Makes the Stock Look Even Cheaper
Mondeum Capital (UK) Limited

NVIDIA beat earnings expectations, but the stock still slipped. Shares fell 1.8% on Thursday after the report, then bounced back 0.8% in premarket trading Friday. For investors wondering about this muted response, the explanation is pretty straightforward. The stock is now cheaper than before the results, and most of Wall Street remains bullish. Here’s how the valuation looks now.
NVIDIA now trades at a forward price-to-earnings ratio just above 22, down from about 26 before the earnings report. This is a big discount compared to its peers. Intel trades at more than 95 times forward earnings, and Advanced Micro Devices is at nearly 47 times. It is unusual for the leading AI chip company to have the lowest multiple among major chipmakers.
Analysts were almost all positive about the results. About 93% of those covering the stock have a Buy rating or something similar. The average price target is now around $294. Benchmark Research raised its target to $335 from $250 and kept its Buy rating. They say investors are so used to Nvidia beating expectations that it no longer leads to a big change in the stock price.
If the market keeps seeing Nvidia’s strong results as business as usual, the gap in valuation with its peers could keep growing until something happens to change investors’ minds.
Recent news

IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]

Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]

Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.
Featured Courses